Global Nucleic Vaccine Market Growth 2025-2031

December 2025 | 107 pages | ID: GEA445FF7DCEEN
LP Information

Abstracts

The global Nucleic Vaccine market size is predicted to grow from US$ 54090 million in 2025 to US$ 63450 million in 2031; it is expected to grow at a CAGR of 2.7% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

A Nucleic Vaccine is a type of vaccine that uses genetic material, such as DNA or RNA, to stimulate an immune response. This innovative approach allows for the development of vaccines against various infectious diseases.

The market for Nucleic Vaccines is driven by advancements in biotechnology and vaccine research. Trends include the development of mRNA vaccines, rapid vaccine production platforms, and ongoing research for applications in infectious disease prevention.

LP Information, Inc. (LPI) ' newest research report, the “Nucleic Vaccine Industry Forecast” looks at past sales and reviews total world Nucleic Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Nucleic Vaccine sales for 2025 through 2031. With Nucleic Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Nucleic Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nucleic Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Preventive Nucleic Vaccine
• Therapeutic Nucleic Vaccine

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Moderna
• CureVac
• Inovio
• Sanofi
• GSK
• CNBG
• Hualan Bio
• Zhifei Shengwu
• Liaoning Chengda
• BioKangtai
• CanSinoBIO
• Walvax Biotechnology
• Fosun Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nucleic Vaccine market?

What factors are driving Nucleic Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nucleic Vaccine market opportunities vary by end market size?

How does Nucleic Vaccine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nucleic Vaccine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Nucleic Vaccine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Nucleic Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Nucleic Vaccine Segment by Type
  2.2.1 Preventive Nucleic Vaccine
  2.2.2 Therapeutic Nucleic Vaccine
2.3 Nucleic Vaccine Sales by Type
  2.3.1 Global Nucleic Vaccine Sales Market Share by Type (2020-2025)
  2.3.2 Global Nucleic Vaccine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Nucleic Vaccine Sale Price by Type (2020-2025)
2.4 Nucleic Vaccine Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Nucleic Vaccine Sales by Application
  2.5.1 Global Nucleic Vaccine Sale Market Share by Application (2020-2025)
  2.5.2 Global Nucleic Vaccine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Nucleic Vaccine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Nucleic Vaccine Breakdown Data by Company
  3.1.1 Global Nucleic Vaccine Annual Sales by Company (2020-2025)
  3.1.2 Global Nucleic Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Nucleic Vaccine Annual Revenue by Company (2020-2025)
  3.2.1 Global Nucleic Vaccine Revenue by Company (2020-2025)
  3.2.2 Global Nucleic Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Nucleic Vaccine Sale Price by Company
3.4 Key Manufacturers Nucleic Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Nucleic Vaccine Product Location Distribution
  3.4.2 Players Nucleic Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NUCLEIC VACCINE BY GEOGRAPHIC REGION

4.1 World Historic Nucleic Vaccine Market Size by Geographic Region (2020-2025)
  4.1.1 Global Nucleic Vaccine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Nucleic Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Nucleic Vaccine Market Size by Country/Region (2020-2025)
  4.2.1 Global Nucleic Vaccine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Nucleic Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nucleic Vaccine Sales Growth
4.4 APAC Nucleic Vaccine Sales Growth
4.5 Europe Nucleic Vaccine Sales Growth
4.6 Middle East & Africa Nucleic Vaccine Sales Growth

5 AMERICAS

5.1 Americas Nucleic Vaccine Sales by Country
  5.1.1 Americas Nucleic Vaccine Sales by Country (2020-2025)
  5.1.2 Americas Nucleic Vaccine Revenue by Country (2020-2025)
5.2 Americas Nucleic Vaccine Sales by Type (2020-2025)
5.3 Americas Nucleic Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nucleic Vaccine Sales by Region
  6.1.1 APAC Nucleic Vaccine Sales by Region (2020-2025)
  6.1.2 APAC Nucleic Vaccine Revenue by Region (2020-2025)
6.2 APAC Nucleic Vaccine Sales by Type (2020-2025)
6.3 APAC Nucleic Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Nucleic Vaccine by Country
  7.1.1 Europe Nucleic Vaccine Sales by Country (2020-2025)
  7.1.2 Europe Nucleic Vaccine Revenue by Country (2020-2025)
7.2 Europe Nucleic Vaccine Sales by Type (2020-2025)
7.3 Europe Nucleic Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nucleic Vaccine by Country
  8.1.1 Middle East & Africa Nucleic Vaccine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Nucleic Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Nucleic Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Nucleic Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nucleic Vaccine
10.3 Manufacturing Process Analysis of Nucleic Vaccine
10.4 Industry Chain Structure of Nucleic Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Nucleic Vaccine Distributors
11.3 Nucleic Vaccine Customer

12 WORLD FORECAST REVIEW FOR NUCLEIC VACCINE BY GEOGRAPHIC REGION

12.1 Global Nucleic Vaccine Market Size Forecast by Region
  12.1.1 Global Nucleic Vaccine Forecast by Region (2026-2031)
  12.1.2 Global Nucleic Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Nucleic Vaccine Forecast by Type (2026-2031)
12.7 Global Nucleic Vaccine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Moderna
  13.1.1 Moderna Company Information
  13.1.2 Moderna Nucleic Vaccine Product Portfolios and Specifications
  13.1.3 Moderna Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Moderna Main Business Overview
  13.1.5 Moderna Latest Developments
13.2 CureVac
  13.2.1 CureVac Company Information
  13.2.2 CureVac Nucleic Vaccine Product Portfolios and Specifications
  13.2.3 CureVac Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 CureVac Main Business Overview
  13.2.5 CureVac Latest Developments
13.3 Inovio
  13.3.1 Inovio Company Information
  13.3.2 Inovio Nucleic Vaccine Product Portfolios and Specifications
  13.3.3 Inovio Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Inovio Main Business Overview
  13.3.5 Inovio Latest Developments
13.4 Sanofi
  13.4.1 Sanofi Company Information
  13.4.2 Sanofi Nucleic Vaccine Product Portfolios and Specifications
  13.4.3 Sanofi Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Sanofi Main Business Overview
  13.4.5 Sanofi Latest Developments
13.5 GSK
  13.5.1 GSK Company Information
  13.5.2 GSK Nucleic Vaccine Product Portfolios and Specifications
  13.5.3 GSK Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 GSK Main Business Overview
  13.5.5 GSK Latest Developments
13.6 CNBG
  13.6.1 CNBG Company Information
  13.6.2 CNBG Nucleic Vaccine Product Portfolios and Specifications
  13.6.3 CNBG Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 CNBG Main Business Overview
  13.6.5 CNBG Latest Developments
13.7 Hualan Bio
  13.7.1 Hualan Bio Company Information
  13.7.2 Hualan Bio Nucleic Vaccine Product Portfolios and Specifications
  13.7.3 Hualan Bio Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Hualan Bio Main Business Overview
  13.7.5 Hualan Bio Latest Developments
13.8 Zhifei Shengwu
  13.8.1 Zhifei Shengwu Company Information
  13.8.2 Zhifei Shengwu Nucleic Vaccine Product Portfolios and Specifications
  13.8.3 Zhifei Shengwu Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Zhifei Shengwu Main Business Overview
  13.8.5 Zhifei Shengwu Latest Developments
13.9 Liaoning Chengda
  13.9.1 Liaoning Chengda Company Information
  13.9.2 Liaoning Chengda Nucleic Vaccine Product Portfolios and Specifications
  13.9.3 Liaoning Chengda Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Liaoning Chengda Main Business Overview
  13.9.5 Liaoning Chengda Latest Developments
13.10 BioKangtai
  13.10.1 BioKangtai Company Information
  13.10.2 BioKangtai Nucleic Vaccine Product Portfolios and Specifications
  13.10.3 BioKangtai Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 BioKangtai Main Business Overview
  13.10.5 BioKangtai Latest Developments
13.11 CanSinoBIO
  13.11.1 CanSinoBIO Company Information
  13.11.2 CanSinoBIO Nucleic Vaccine Product Portfolios and Specifications
  13.11.3 CanSinoBIO Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 CanSinoBIO Main Business Overview
  13.11.5 CanSinoBIO Latest Developments
13.12 Walvax Biotechnology
  13.12.1 Walvax Biotechnology Company Information
  13.12.2 Walvax Biotechnology Nucleic Vaccine Product Portfolios and Specifications
  13.12.3 Walvax Biotechnology Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Walvax Biotechnology Main Business Overview
  13.12.5 Walvax Biotechnology Latest Developments
13.13 Fosun Pharma
  13.13.1 Fosun Pharma Company Information
  13.13.2 Fosun Pharma Nucleic Vaccine Product Portfolios and Specifications
  13.13.3 Fosun Pharma Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Fosun Pharma Main Business Overview
  13.13.5 Fosun Pharma Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Nucleic Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Nucleic Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Preventive Nucleic Vaccine
Table 4. Major Players of Therapeutic Nucleic Vaccine
Table 5. Global Nucleic Vaccine Sales by Type (2020-2025) & (K Units)
Table 6. Global Nucleic Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global Nucleic Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Nucleic Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global Nucleic Vaccine Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Nucleic Vaccine Sale by Application (2020-2025) & (K Units)
Table 11. Global Nucleic Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Nucleic Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Nucleic Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Nucleic Vaccine Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Nucleic Vaccine Sales by Company (2020-2025) & (K Units)
Table 16. Global Nucleic Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Nucleic Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Nucleic Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Nucleic Vaccine Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Nucleic Vaccine Producing Area Distribution and Sales Area
Table 21. Players Nucleic Vaccine Products Offered
Table 22. Nucleic Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Nucleic Vaccine Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Nucleic Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Nucleic Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Nucleic Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Nucleic Vaccine Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Nucleic Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Nucleic Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Nucleic Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Nucleic Vaccine Sales by Country (2020-2025) & (K Units)
Table 34. Americas Nucleic Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Nucleic Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Nucleic Vaccine Sales by Type (2020-2025) & (K Units)
Table 37. Americas Nucleic Vaccine Sales by Application (2020-2025) & (K Units)
Table 38. APAC Nucleic Vaccine Sales by Region (2020-2025) & (K Units)
Table 39. APAC Nucleic Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Nucleic Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Nucleic Vaccine Sales by Type (2020-2025) & (K Units)
Table 42. APAC Nucleic Vaccine Sales by Application (2020-2025) & (K Units)
Table 43. Europe Nucleic Vaccine Sales by Country (2020-2025) & (K Units)
Table 44. Europe Nucleic Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Nucleic Vaccine Sales by Type (2020-2025) & (K Units)
Table 46. Europe Nucleic Vaccine Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Nucleic Vaccine Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Nucleic Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Nucleic Vaccine Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Nucleic Vaccine Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Nucleic Vaccine
Table 52. Key Market Challenges & Risks of Nucleic Vaccine
Table 53. Key Industry Trends of Nucleic Vaccine
Table 54. Nucleic Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Nucleic Vaccine Distributors List
Table 57. Nucleic Vaccine Customer List
Table 58. Global Nucleic Vaccine Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Nucleic Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Nucleic Vaccine Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Nucleic Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Nucleic Vaccine Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Nucleic Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Nucleic Vaccine Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Nucleic Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Nucleic Vaccine Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Nucleic Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Nucleic Vaccine Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Nucleic Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Nucleic Vaccine Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Nucleic Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Moderna Basic Information, Nucleic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Moderna Nucleic Vaccine Product Portfolios and Specifications
Table 74. Moderna Nucleic Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Moderna Main Business
Table 76. Moderna Latest Developments
Table 77. CureVac Basic Information, Nucleic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. CureVac Nucleic Vaccine Product Portfolios and Specifications
Table 79. CureVac Nucleic Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. CureVac Main Business
Table 81. CureVac Latest Developments
Table 82. Inovio Basic Information, Nucleic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Inovio Nucleic Vaccine Product Portfolios and Specifications
Table 84. Inovio Nucleic Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Inovio Main Business
Table 86. Inovio Latest Developments
Table 87. Sanofi Basic Information, Nucleic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Sanofi Nucleic Vaccine Product Portfolios and Specifications
Table 89. Sanofi Nucleic Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Sanofi Main Business
Table 91. Sanofi Latest Developments
Table 92. GSK Basic Information, Nucleic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Nucleic Vaccine Product Portfolios and Specifications
Table 94. GSK Nucleic Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. CNBG Basic Information, Nucleic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. CNBG Nucleic Vaccine Product Portfolios and Specifications
Table 99. CNBG Nucleic Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. CNBG Main Business
Table 101. CNBG Latest Developments
Table 102. Hualan Bio Basic Information, Nucleic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Hualan Bio Nucleic Vaccine Product Portfolios and Specifications
Table 104. Hualan Bio Nucleic Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Hualan Bio Main Business
Table 106. Hualan Bio Latest Developments
Table 107. Zhifei Shengwu Basic Information, Nucleic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Zhifei Shengwu Nucleic Vaccine Product Portfolios and Specifications
Table 109. Zhifei Shengwu Nucleic Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Zhifei Shengwu Main Business
Table 111. Zhifei Shengwu Latest Developments
Table 112. Liaoning Chengda Basic Information, Nucleic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Liaoning Chengda Nucleic Vaccine Product Portfolios and Specifications
Table 114. Liaoning Chengda Nucleic Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Liaoning Chengda Main Business
Table 116. Liaoning Chengda Latest Developments
Table 117. BioKangtai Basic Information, Nucleic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. BioKangtai Nucleic Vaccine Product Portfolios and Specifications
Table 119. BioKangtai Nucleic Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. BioKangtai Main Business
Table 121. BioKangtai Latest Developments
Table 122. CanSinoBIO Basic Information, Nucleic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. CanSinoBIO Nucleic Vaccine Product Portfolios and Specifications
Table 124. CanSinoBIO Nucleic Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. CanSinoBIO Main Business
Table 126. CanSinoBIO Latest Developments
Table 127. Walvax Biotechnology Basic Information, Nucleic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Walvax Biotechnology Nucleic Vaccine Product Portfolios and Specifications
Table 129. Walvax Biotechnology Nucleic Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Walvax Biotechnology Main Business
Table 131. Walvax Biotechnology Latest Developments
Table 132. Fosun Pharma Basic Information, Nucleic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Fosun Pharma Nucleic Vaccine Product Portfolios and Specifications
Table 134. Fosun Pharma Nucleic Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Fosun Pharma Main Business
Table 136. Fosun Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Nucleic Vaccine
Figure 2. Nucleic Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nucleic Vaccine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Nucleic Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Nucleic Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Nucleic Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Nucleic Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Preventive Nucleic Vaccine
Figure 12. Product Picture of Therapeutic Nucleic Vaccine
Figure 13. Global Nucleic Vaccine Sales Market Share by Type in 2025
Figure 14. Global Nucleic Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. Nucleic Vaccine Consumed in Hospital
Figure 16. Global Nucleic Vaccine Market: Hospital (2020-2025) & (K Units)
Figure 17. Nucleic Vaccine Consumed in Clinic
Figure 18. Global Nucleic Vaccine Market: Clinic (2020-2025) & (K Units)
Figure 19. Nucleic Vaccine Consumed in Others
Figure 20. Global Nucleic Vaccine Market: Others (2020-2025) & (K Units)
Figure 21. Global Nucleic Vaccine Sale Market Share by Application (2024)
Figure 22. Global Nucleic Vaccine Revenue Market Share by Application in 2025
Figure 23. Nucleic Vaccine Sales by Company in 2025 (K Units)
Figure 24. Global Nucleic Vaccine Sales Market Share by Company in 2025
Figure 25. Nucleic Vaccine Revenue by Company in 2025 ($ millions)
Figure 26. Global Nucleic Vaccine Revenue Market Share by Company in 2025
Figure 27. Global Nucleic Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Nucleic Vaccine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Nucleic Vaccine Sales 2020-2025 (K Units)
Figure 30. Americas Nucleic Vaccine Revenue 2020-2025 ($ millions)
Figure 31. APAC Nucleic Vaccine Sales 2020-2025 (K Units)
Figure 32. APAC Nucleic Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Europe Nucleic Vaccine Sales 2020-2025 (K Units)
Figure 34. Europe Nucleic Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Nucleic Vaccine Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Nucleic Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Americas Nucleic Vaccine Sales Market Share by Country in 2025
Figure 38. Americas Nucleic Vaccine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Nucleic Vaccine Sales Market Share by Type (2020-2025)
Figure 40. Americas Nucleic Vaccine Sales Market Share by Application (2020-2025)
Figure 41. United States Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Nucleic Vaccine Sales Market Share by Region in 2025
Figure 46. APAC Nucleic Vaccine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Nucleic Vaccine Sales Market Share by Type (2020-2025)
Figure 48. APAC Nucleic Vaccine Sales Market Share by Application (2020-2025)
Figure 49. China Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Nucleic Vaccine Sales Market Share by Country in 2025
Figure 57. Europe Nucleic Vaccine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Nucleic Vaccine Sales Market Share by Type (2020-2025)
Figure 59. Europe Nucleic Vaccine Sales Market Share by Application (2020-2025)
Figure 60. Germany Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. France Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Nucleic Vaccine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Nucleic Vaccine Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Nucleic Vaccine Sales Market Share by Application (2020-2025)
Figure 68. Egypt Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Nucleic Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Nucleic Vaccine in 2025
Figure 74. Manufacturing Process Analysis of Nucleic Vaccine
Figure 75. Industry Chain Structure of Nucleic Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Nucleic Vaccine Sales Market Forecast by Region (2026-2031)
Figure 78. Global Nucleic Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Nucleic Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Nucleic Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Nucleic Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Nucleic Vaccine Revenue Market Share Forecast by Application (2026-2031)